Evolutionary and spatiotemporal analyses reveal multiple introductions and cryptic transmission of SARS-CoV-2 VOC/VOI in Malta.
SARS-CoV-2
epidemiology
next-generation sequencing
phylodynamics
Journal
Microbiology spectrum
ISSN: 2165-0497
Titre abrégé: Microbiol Spectr
Pays: United States
ID NLM: 101634614
Informations de publication
Date de publication:
06 Oct 2023
06 Oct 2023
Historique:
pubmed:
6
10
2023
medline:
6
10
2023
entrez:
6
10
2023
Statut:
aheadofprint
Résumé
Genomic surveillance and epidemiology have shed light on the viral diversity driving coronavirus disease 2019 (COVID-19) outbreaks and are important during waves of highly transmissible and immune-escaping variants of interest or of concern (VOCs). We analyzed the epidemiological data of the understudied country of Malta and related the patterns observed with viral genetic sequences obtained through the surveillance system headed by the Mater Dei Hospital and the University of Malta. We reconstructed the evolutionary history and spatiotemporal dynamics of Maltese severe acute respiratory syndrome coronavirus 2 viruses using a phylodynamics framework. Our findings suggest that the number of cases associated with B.1.1.7/Alpha, B.1.617.2.X/Delta, and B.1.1.529.X/Omicron VOCs was nine times higher than those associated with wild-type variants. The positivity rates in Malta remained low to moderate (<10%). A combination of public health interventions appeared to have allowed Malta to mitigate the impact of COVID-19. Our phylodynamic reconstruction traced most of the 173 viral introductions inferred to countries in Northern Europe, which is consistent with flight connectivity patterns. We also observed prolonged periods of cryptic transmission (median = 102 days) until expansion into larger outbreaks. These larger outbreaks were more easily detected by the intermittent genomic surveillance in Malta, characterized by periods of sequencing hiatus. Our study demonstrates that integrating epidemiological and genomic data are crucial for uncovering the COVID-19 dynamics of understudied locations, particularly when genomic surveillance is suboptimal. Accordingly, strengthening the genomic surveillance system in Malta should help in the earlier detection of introductions and minimize viral expansion in the country while informing public health interventions. IMPORTANCE Our study provides insights into the evolution of the coronavirus disease 2019 (COVID-19) pandemic in Malta, a highly connected and understudied country. We combined epidemiological and phylodynamic analyses to analyze trends in the number of new cases, deaths, tests, positivity rates, and evolutionary and dispersal patterns from August 2020 to January 2022. Our reconstructions inferred 173 independent severe acute respiratory syndrome coronavirus 2 introductions into Malta from various global regions. Our study demonstrates that characterizing epidemiological trends coupled with phylodynamic modeling can inform the implementation of public health interventions to help control COVID-19 transmission in the community.
Identifiants
pubmed: 37800925
doi: 10.1128/spectrum.01539-23
pmc: PMC10714767
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0153923Subventions
Organisme : NIAID NIH HHS
ID : P01 AI152999
Pays : United States
Références
BMC Evol Biol. 2017 Jan 13;17(1):16
pubmed: 28086751
Nature. 2021 Apr;592(7854):438-443
pubmed: 33690265
Virus Evol. 2018 Jan 08;4(1):vex042
pubmed: 29340210
JCI Insight. 2021 Mar 22;6(6):
pubmed: 33749660
Lancet Reg Health Eur. 2021 Sep;8:100185
pubmed: 34345876
Commun Med (Lond). 2022 Jan 28;2:10
pubmed: 35603268
Euro Surveill. 2017 Mar 30;22(13):
pubmed: 28382917
J Community Health. 2021 Jun;46(3):618-625
pubmed: 32936428
Obes Sci Pract. 2016 Dec;2(4):466-470
pubmed: 28090352
PLoS One. 2020 Oct 15;15(10):e0239389
pubmed: 33057434
Glob Chall. 2017 Jan 10;1(1):33-46
pubmed: 31565258
Science. 2020 May 1;368(6490):493-497
pubmed: 32213647
Science. 2020 Oct 30;370(6516):571-575
pubmed: 32913002
Genome Med. 2018 Jun 29;10(1):46
pubmed: 29954441
Z Gesundh Wiss. 2022;30(11):2641-2648
pubmed: 33643778
J R Soc Interface. 2022 Jun;19(191):20210900
pubmed: 35670221
Int J Environ Res Public Health. 2021 Sep 18;18(18):
pubmed: 34574790
Nature. 2022 Mar;603(7902):679-686
pubmed: 35042229
EClinicalMedicine. 2021 Jul 31;39:101064
pubmed: 34401689
PLoS Pathog. 2021 May 20;17(5):e1009571
pubmed: 34015049
Nat Genet. 2021 Oct;53(10):1405-1414
pubmed: 34594042
Lancet Microbe. 2021 Sep;2(9):e481-e484
pubmed: 34337584
Nature. 2021 Jul;595(7869):707-712
pubmed: 34098568
Z Gesundh Wiss. 2022;30(2):459-464
pubmed: 32837836
iScience. 2022 Mar 18;25(3):103880
pubmed: 35156006
Nat Commun. 2022 Sep 6;13(1):5240
pubmed: 36068236
Science. 2021 Feb 12;371(6530):708-712
pubmed: 33419936
Nat Microbiol. 2021 Jul;6(7):821-823
pubmed: 34108654
Cell. 2021 Apr 15;184(8):2201-2211.e7
pubmed: 33743891
Lancet. 2021 Dec 4;398(10316):2109-2124
pubmed: 34762857
Mol Biol Evol. 2020 May 1;37(5):1530-1534
pubmed: 32011700
Front Public Health. 2022 Sep 23;10:1018505
pubmed: 36211652
Virus Evol. 2016 Apr 09;2(1):vew007
pubmed: 27774300
Nat Microbiol. 2022 Sep;7(9):1490-1500
pubmed: 35982313
Nature. 2021 May;593(7858):266-269
pubmed: 33767447
Eur J Public Health. 2022 Apr 1;32(2):316-321
pubmed: 34978569